Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

DT-095895 demonstrates efficacy in syngeneic mouse models of cancer

July 21, 2020

HH-2710 shows efficacy in xenograft models of MAPK-mutant tumors

July 21, 2020

GlaxoSmithKline begins phase I study of GSK-6097608 in advanced solid tumors

July 21, 2020

First patient dosed in phase I/II study of bemcentinib in GBM

July 20, 2020

Protein degradation system targeted to KRAS

July 20, 2020

Hangzhou Bio-Creativity Pharma-Tech divulges CDK inhibitors

July 20, 2020

Medshine Discovery identifies FGFR and VEGFR dual inhibitors

July 20, 2020

Chinese researchers divulge hSTING agonists

July 20, 2020

Sichuan Kelun-Biotech Biopharmaceutical discloses adenosine A2A receptor antagonists

July 20, 2020

Shanghai Zheye Biotechnology patents ACVR1 inhibitors

July 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...